Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Ishares Msci Spain ETF (EWP) vs Twist Bioscience Corp (TWST) Price & Performance

Ishares Msci Spain ETFTrade
Twist Bioscience CorpTrade

Price performance (Past 24H)

Key statistics

Ishares Msci Spain ETF vs Twist Bioscience Corp — how do they compare? Ishares Msci Spain ETF trades at $59.21, while Twist Bioscience Corp trades at $91.49 (market cap $5.76B). Which is the better fit depends on your goals.

EWPTWST
Sector
Broad Market / FactorHealth
52-Week High
$60.28$102.88
52-Week Low
$43.90$24.16
Market Cap
$5.76B
Enterprise Value
$5.69B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ishares Msci Spain ETF

No Aura AI signal available yet.

Twist Bioscience Corp

Twist Bioscience (TWST) trades at $92.61, up 2.5% on the day, with a bullish technical signal and strong analyst support. The company shows improving revenue growth ($377M in 2025, up 20% year-over-year) but continues to report significant losses (-$77.7M net income). Recent AI-driven drug discovery collaborations and product expansions provide growth catalysts, though persistent negative cash flow and insider selling present concerns.

Outlook remains cautiously optimistic with 79% analyst buy ratings and a $91.63 consensus target. Investment opportunity centers on AI-enabled synthetic biology growth, while risks include sustained profitability challenges, cash burn, and competitive pressures in genomics. The stock trades at premium valuations (P/S 13.74) despite negative margins.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Ishares Msci Spain ETF

EWP is a country-specific ETF that tracks the performance of the Spanish equity market. It provides targeted access to large and mid-sized companies in Spain, with heavy weightings in financials and utilities like Banco Santander and Iberdrola.

Read more on EWP

About Twist Bioscience Corp

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.

Read more on TWST